METHOD FOR SELECTION OF TREATMENT MODALITY IN IMPAIRED RECEPTIVENESS OF ENDOMETRIUM IN WOMEN OF CHILD-BEARING AGE WITH INFERTILITY

摘要

A method for selection of the treatment modality in impaired receptiveness of endometrium in the women of child-bearing age with infertility provides for diagnosing the type of the impairment by examining morphofunctional state of endometrium and the its match to the phase of menstrual cycle on the day of anticipated implantation window, analyzing the impairment of immune and antioxidant reactivity, and diagnosing the metabolic disorders. Depending on the results of examination, the treatment modality is chosen. In addition, hyper- or hypoproduction of CD16+CD56+UNK-cells are assayed. Within the first month of the therapy all the patients are provided with the course of 10 injection of Inflamafertin. Vitamin E per os is prescribed within 3 months on Days 15-26 of the menstrual cycle. Within the 2nd and 3d months of the therapy, Galavit is injected daily at a dose of or is provided in the form of suppositories twice a day on Days 15-25 of the menstrual cycle when hyperproduction of CD16+CD56+UNK-cells is found out. In case of hypoproduction of CD16+CD56+UNK-cells, Galavit is injected daily at a dose of and suppositories of Galavit are used once a day.